companydata.dkcompanydata.dk

ZP SPV 3 K/S: Financial statements 2025

CVR: 41038039

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

ZP SPV 3 K/S (CVR 41038039) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,039,000 compared with DKK -34,739,000 the year before. Equity in the 2025 report amounted to DKK 429,000. The solvency ratio was 47.7%.

Revenue
DKK 0
Profit/Loss
DKK -1,039,000
Equity
DKK 429,000
Total Assets
DKK 899,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202500-1M429K-
20246.8M6.8M-34.7M1.5M-
20237.4M7.4M1.1M36.2M-
202237.8M37.8M-1.8M35.2M-
20211.6M USD1.6M USD50K USD5.6M USD-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ZP SPV 3 K/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

ZP SPV 3 K/S: The 2024 annual report is outApr 28, 2025

ZP SPV 3 K/S has published its annual report for 2024. Revenue came to DKK 6,783,000, and the net result was DKK -34,739,000.

About ZP SPV 3 K/S

ZP SPV 3 K/S is a Danish company of the type Kommanditselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of ZP General Partner 3 ApS. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,039,000 compared with DKK -34,739,000 the year before. Equity in the 2025 report amounted to DKK 429,000.

Source: annual report 2025, Danish Business Authority

Other financial years